A Phase II Study of Palbociclib for Recurrent or Refractory Advanced Thymic Epithelial Tumor (KCSG LU17-21).
Journal of Clinical Oncology（2021）
Key words
Palbociclib,Cyclin D1,Thymic Epithelial Tumors
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined